Cancer Drug Market By Cancer Type (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Lung/Respiratory, Prostate Cancer, Skin Cancer, Other Cancer), By Therapeutics (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others) - Industry Size, Growth, Share And Forecast To 2026
Cancer drugs are theurapeutics based treatment procedures that help to treat cancer. The global cancer drug demand is primarily driven due to increasing incidences of cancer globally coupled with increasing research and development on biological and targeted drug therapies for cancer and increasing research and development of novel approaches to cancer treatment. Global cancer drug market is expected to grow with a CAGR of 7% over the forecast period of 2019 to 2026. Furthermore, the onset of personalized medicine approach is offering huge growth opportunity for the market.
Cancer is one of the most common malignancies globally, it is considered as the second leading cause of death after cardiovascular diseases such as coronary heart disease, cardiac arrest. As per Cancer Research UK, a total of 9.6 million died due to cancer in 2018 and a total 17 million new cases of cancer have been identified globally in 2018. There is a global consensus towards development of new and novel approaches to cure cancer globally. Universities, institutions, governments, foundation and private companies globally are making continuous efforts for the development of novel medicines to reduce the burden and societal cost of cancer and other chronic diseases.
Global cancer drug market report covers segmentation analysis of therapeutics and cancer type. Based on therapeutics the market is sub segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others. Chemotherapy is expected to be highest revenue generating segment and is expected to be fastest growing segment for the global cancer drug market. Based on cancer type the report is sub segmented into blood cancer, breast cancer, gastrointestinal, prostate, respiratory/lung, skin and others. Blood cancer is expected to fastest growing segment of cancer type segment with lung cancer as a fastest growing segment due to growing prevalence of lung diseases.
North America accounted for the largest market share in terms of revenue for the cancer drug market followed by Asia Pacific and Europe in 2017. High public and private funding for the development of new cancer drugs coupled with high healthcare expenditure and presence of sound healthcare infrastructure contributes to the dominance of North America cancer drug market during the forecast period. Moreover, Asia Pacific region is expected to be the fastest growing region in cancer drug market during the forecast period. Factors such as increasing focus towards the development of biosimilars and high prevalence of different type of cancer are some of the major factors which contributes to the fastest growth rate of Asia Pacific cancer drug market during the forecast period.
The major market players of the global cancer drug market are F. Hoffmann-La Roche Ltd (Switzerland), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Bayer Ag (Germany) Roche Diagnostics (Switzerland) and Others. The companies in the market to increase their dominance are inclined towards collaborative research for new product development. For instance, in January 2016, AstraZeneca and Moderna therapeutics announced a collaboration for the development, and co-commercialization of messenger RNA (mRNA) therapeutic for the treatment cardiovascular, metabolic and renal diseases as well as selected targets in oncology. Similarly, in July 2017 AstraZeneca and Merck Corp. announced their collaboration for the development of new potential for the treatment of a range of tumor types.
1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2. Executive Summary
2.1. Market Snapshot: Global Cancer Drug Market
2.1.1. Global Cancer Drug Market, by Type, 2018 (US$ Mn)
2.1.2. Global Cancer Drug Market, by Therapeutics, 2018 (US$ Mn)
2.1.3. Global Cancer Drug Market, by Geography, 2018 (US$ Mn)
3. Market Dynamics
3.1. Introduction
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Increasing Prevalence of Cancer
3.2.1.2. Increasing Research and Development on Biological Therapies
3.2.1.3. Growing Importance of Biological and Targeted Drug Therapies
3.2.2. Market Restraints
3.2.2.1. High Cost of Drug Development
3.2.3. Market Opportunities
3.2.3.1. Advancements in Anti-Cancer Drug Research
3.2.3.2. Expiration of Key Patents and Biosimilars
3.2.4. Market Challenges
3.2.4.1. Adverse Effect of Anti-Cancer Drug Therapy
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market share of Key Players, 2018
3.5. Top five findings and strategic analysis
4. Global Cancer Drug Market, by Cancer Type
4.1. Overview
4.1.1. Global Cancer Drug Market Value Share, by Cancer Type, 2018 & 2026 (Value, %)
4.1.2. Global Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
4.2. Blood Cancer
4.2.1. Global Cancer Drug Market for Blood Cancer, 2019-2026 (US$ Mn)
4.2.2. Global Cancer Drug Market for Blood Cancer, by Region 2019-2026 (US$ Mn)
4.3. Breast Cancer
4.3.1. Global Cancer Drug Market for Breast Cancer, 2019-2026 (US$ Mn)
4.3.2. Global Cancer Drug Market for Breast Cancer, by Region 2019-2026 (US$ Mn)
4.4. Gastrointestinal Cancer
4.4.1. Global Cancer Drug Market for Gastrointestinal cancer, 2019-2026 (US$ Mn)
4.4.2. Global Cancer Drug Market for Gastrointestinal cancer, by Region 2019-2026 (US$ Mn)
4.5. Lung/Respiratory
4.5.1. Global Cancer Drug Market for Lung/Respiratory, 2019-2026 (US$ Mn)
4.5.2. Global Cancer Drug Market for Lung/Respiratory, by Region 2019-2026 (US$ Mn)
4.6. Prostate Cancer
4.6.1. Global Cancer Drug Market for Prostate Cancer, 2019-2026 (US$ Mn)
4.6.2. Global Cancer Drug Market for Prostate Cancer, by Region 2019-2026 (US$ Mn)
4.7. Skin Cancer
4.7.1. Global Cancer Drug Market for Skin Cancer, 2019-2026 (US$ Mn)
4.7.2. Global Cancer Drug Market for Skin Cancer, by Region 2019-2026 (US$ Mn)
4.8. Other Cancer
4.8.1. Global Cancer Drug Market for Other Cancer, 2019-2026 (US$ Mn)
4.8.2. Global Cancer Drug Market for Other Cancer, by Region 2019-2026 (US$ Mn)
5. Global Cancer Drug Market, by Therapeutics
5.1. Overview
5.1.1. Global Cancer Drug Market Value Share, by Therapeutics, 2018 & 2026 (Value, %)
5.1.2. Global Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
5.2. Chemotherapy
5.2.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.2.2. Global Cancer Drug Market for Chemotherapy, 2019-2026 (US$ Mn)
5.2.3. Global Cancer Drug Market for Chemotherapy, by Region 2019-2026 (US$ Mn)
5.3. Targeted Therapy
5.3.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.3.2. Global Cancer Drug Market for Targeted Therapy, 2019-2026 (US$ Mn)
5.3.3. Global Cancer Drug Market for Targeted Therapy, by Region 2019-2026 (US$ Mn)
5.4. Immunotherapy
5.4.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.4.2. Global Cancer Drug Market for Immunotherapy, 2019-2026 (US$ Mn)
5.4.3. Global Cancer Drug Market for Immunotherapy, by Region 2019-2026 (US$ Mn)
5.5. Hormonal Therapy
5.5.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.5.2. Global Cancer Drug Market for Hormonal Therapy 2019-2026 (US$ Mn)
5.5.3. Global Cancer Drug Market for Hormonal Therapy, by Region 2019-2026 (US$ Mn)
5.6. Others
5.6.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
5.6.2. Global Cancer Drug Market for Others, 2019-2026 (US$ Mn)
5.6.3. Global Cancer Drug Market for Others, by Region 2019-2026 (US$ Mn)
6. North America Cancer Drug Market Analysis
6.1. Overview
6.1.1. North America Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
6.1.2. North America Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
6.1.3. North America Cancer Drug Market, by Country, 2019-2026 (US$ Mn)
6.1.3.1. United States
6.1.3.1.1. United States Cancer Drug Market 2019 – 2026 (US$ Mn)
6.1.3.2. Canada
6.1.3.2.1. Canada Cancer Drug Market 2019 – 2026 (US$ Mn)
7. Europe Cancer Drug Market Analysis
7.1. Overview
7.1.1. Europe Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
7.1.2. Europe Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
7.1.3. Europe Cancer Drug Market, by Country/Region, 2019-2026 (US$ Mn)
7.1.3.1. UK
7.1.3.1.1. UK Cancer Drug Market 2019 – 2026 (US$ Mn)
7.1.3.2. Germany
7.1.3.2.1. Germany Cancer Drug Market 2019 – 2026 (US$ Mn)
7.1.3.3. France
7.1.3.3.1. France Cancer Drug Market 2019 – 2026 (US$ Mn)
7.1.3.4. Rest of Europe
7.1.3.4.1. Rest of Europe Cancer Drug Market 2019 – 2026 (US$ Mn)
8. Asia Pacific Cancer Drug Market Analysis
8.1. Overview
8.1.1. Asia Pacific Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
8.1.2. Asia Pacific Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
8.1.3. Asia Pacific Cancer Drug Market, by Country/Region, 2019-2026 (US$ Mn)
8.1.3.1. China
8.1.3.1.1. China Cancer Drug Market 2019 – 2026 (US$ Mn)
8.1.3.2. India
8.1.3.2.1. India Cancer Drug Market 2019 – 2026 (US$ Mn)
8.1.3.3. Japan
8.1.3.3.1. Japan Cancer Drug Market 2019 – 2026 (US$ Mn)
8.1.3.4. Rest of Asia Pacific
8.1.3.4.1. Rest of Asia Pacific Cancer Drug Market 2019 – 2026 (US$ Mn)
9. Rest of the World Cancer Drug Market Analysis
9.1. Overview
9.1.1. Rest of the World Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
9.1.2. Rest of the World Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
9.1.3. Rest of the World Cancer Drug Market, by Country/Region, 2019 – 2026 (US$ Mn)
9.1.3.1. Latin America
9.1.3.1.1. Latin America Cancer Drug Market 2019 – 2026 (US$ Mn)
9.1.3.2. MENA
9.1.3.2.1. MENA Cancer Drug Market 2019 – 2026 (US$ Mn)
10. Company Profiles
10.1. F. Hoffmann-La Roche Ltd (Switzerland)
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.3. Key Strategies
10.1.4. Key Conclusion
10.2. Eli Lilly and Company (U.S.)
10.2.1. Company Overview
10.2.2. Product Portfolio
10.2.3. Key Strategies
10.2.4. Key Conclusion
10.3. Bayer AG (Germany)
10.3.1. Company Overview
10.3.2. Product Portfolio
10.3.3. Key Strategies
10.3.4. Key Conclusion
10.4. Merck & Co., Inc. (U.S.)
10.4.1. Company Overview
10.4.2. Product Portfolio
10.4.3. Key Strategies
10.4.4. Key Conclusion
10.5. Novartis Ag (Switzerland)
10.5.1. Company Overview
10.5.2. Product Portfolio
10.5.3. Key Strategies
10.5.4. Key Conclusion
10.6. Pfizer Inc (U.S.)
10.6.1. Company Overview
10.6.2. Product Portfolio
10.6.3. Key Strategies
10.6.4. Key Conclusion
10.7. Astrazeneca (UK)
10.7.1. Company Overview
10.7.2. Product Portfolio
10.7.3. Key Strategies
10.7.4. Key Conclusion
10.8. Takeda Pharmaceutical Company Limited (Japan)
10.8.1. Company Overview
10.8.2. Product Portfolio
10.8.3. Key Strategies
10.8.4. Key Conclusion
10.9. Celgene Corporation (U.S.)
10.9.1. Company Overview
10.9.2. Product Portfolio
10.9.3. Key Strategies
10.9.4. Key Conclusion
10.10. Amgen Inc (U.S.)
10.10.1. Company Overview
10.10.2. Product Portfolio
10.10.3. Key Strategies
10.10.4. Key Conclusion
1. Global Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
2. Global Cancer Drug Market for Blood Cancer, by Region 2019-2026 (US$ Mn)
3. Global Cancer Drug Market for Breast Cancer, by Region 2019-2026 (US$ Mn)
4. Global Cancer Drug Market for Gastrointestinal cancer, by Region 2019-2026 (US$ Mn)
5. Global Cancer Drug Market for Lung/Respiratory, by Region 2019-2026 (US$ Mn)
6. Global Cancer Drug Market for Prostate Cancer, by Region 2019-2026 (US$ Mn)
7. Global Cancer Drug Market for Skin Cancer, by Region 2019-2026 (US$ Mn)
8. Global Cancer Drug Market for Other Cancer, by Region 2019-2026 (US$ Mn)
9. Global Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
10. Global Cancer Drug Market for Chemotherapy, by Region 2019-2026 (US$ Mn)
11. Global Cancer Drug Market for Targeted Therapy, by Region 2019-2026 (US$ Mn)
12. Global Cancer Drug Market for Immunotherapy, by Region 2019-2026 (US$ Mn)
13. Global Cancer Drug Market for Hormonal Therapy, by Region 2019-2026 (US$ Mn)
14. Global Cancer Drug Market for Others, by Region 2019-2026 (US$ Mn)
15. Global Cancer Drug Market, by Geography, 2019-2026 (US$ Mn)
16. North America Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
17. North America Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
18. North America Cancer Drug Market, by Country, 2019-2026 (US$ Mn)
19. Europe Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
20. Europe Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
21. Europe Cancer Drug Market, by Country/Region, 2019-2026 (US$ Mn)
22. Asia Pacific Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
23. Asia Pacific Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
24. Asia Pacific Cancer Drug Market, by Country/Region, 2019-2026 (US$ Mn)
25. Rest of the World Cancer Drug Market, by Cancer Type, 2019-2026 (US$ Mn)
26. Rest of the World Cancer Drug Market, by Therapeutics, 2019-2026 (US$ Mn)
27. Rest of the World Cancer Drug Market, by Country/Region, 2019 – 2026 (US$ Mn)
1. Global Cancer Drug Market, by Cancer Type, 2018 (US$ Mn)
2. Global Cancer Drug Market, by Therapeutics, 2018 (US$ Mn)
3. Global Cancer Drug Market, by Geography, 2018 (US$ Mn)
4. Global Cancer Drug Market Value Share, by Cancer Type, 2018 & 2026 (Value, %)
5. Global Cancer Drug Market Value Share, by Therapeutics, 2018 & 2026 (Value, %)
6. Global Cancer Drug Market for Blood Cancer, 2019-2026 (US$ Mn)
7. Global Cancer Drug Market for Breast Cancer, 2019-2026 (US$ Mn)
8. Global Cancer Drug Market for Gastrointestinal cancer, 2019-2026 (US$ Mn)
9. Global Cancer Drug Market for Lung/Respiratory, 2019-2026 (US$ Mn)
10. Global Cancer Drug Market for Prostate Cancer, 2019-2026 (US$ Mn)
11. Global Cancer Drug Market for Skin Cancer, 2019-2026 (US$ Mn)
12. Global Cancer Drug Market for Other Cancer, 2019-2026 (US$ Mn)
13. Global Cancer Drug Market for Chemotherapy, 2019-2026 (US$ Mn)
14. Global Cancer Drug Market for Targeted Therapy, 2019-2026 (US$ Mn)
15. Global Cancer Drug Market for Immunotherapy, 2019-2026 (US$ Mn)
16. Global Cancer Drug Market for Hormonal Therapy 2019-2026 (US$ Mn)
17. Global Cancer Drug Market for Others, 2019-2026 (US$ Mn)
18. United States Cancer Drug Market 2019 – 2026 (US$ Mn)
19. Canada Cancer Drug Market 2019 – 2026 (US$ Mn)
20. UK Cancer Drug Market 2019 – 2026 (US$ Mn)
21. Germany Cancer Drug Market 2019 – 2026 (US$ Mn)
22. France Cancer Drug Market 2019 – 2026 (US$ Mn)
23. Rest of Europe Cancer Drug Market 2019 – 2026 (US$ Mn)
24. China Cancer Drug Market 2019 – 2026 (US$ Mn)
25. India Cancer Drug Market 2019 – 2026 (US$ Mn)
26. Japan Cancer Drug Market 2019 – 2026 (US$ Mn)
27. Rest of Asia Pacific Cancer Drug Market 2019 – 2026 (US$ Mn)
28. Latin America Cancer Drug Market 2019 – 2026 (US$ Mn)
29. MENA Cancer Drug Market 2019 – 2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)